Your Health, We Care
The FIDELITY study showed that the overall incidence of treatment-related adverse events in the finerenone group was comparable to that in the placebo group, with a lower proportion of patients discontinuing treatment due to adverse events.
Finerenone has received consistent high-level recommendations from authoritative guidelines both domestically and internationally due to its clear renal and cardiac benefits, making it an important treatment option for CKD patients related to T2DM.
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
